Incremental improvements in trabeculectomy have proved valuable in refining the technique and include the use of a traction suture to control the position of the eye, appropriate and optimal wound healing techniques to prevent fibrosis and scarring, use of a fornix-based conjunctival flap, creation of a large scleral flap to maximize posterior aqueous flow and enable the development of a diffuse bleb, adjustable sutures to control aqueous flow, and a standardized trabeculectomy aperture. 24, 25 Such refinements can improve patient outcomes. 26, 27 One such incremental advance has been the development of the EX-PRESS ® Glaucoma Filtration Device (GFD), an attempt to standardize trabeculectomy and enable predictable aqueous flow. 28 In the US,
EX-PRESS ® GFD implantation is currently indicated for patients
who have failed to respond to both medications and surgeries such as laser trabeculoplasty. 29 The satellite symposium 'Advances in glaucoma surgery: new evidence in filtration surgery' at the World Glaucoma Congress 2011 examined some of the recent findings evaluating the performance of the EX-PRESS ® GFD and the role it can play in improving conventional trabeculectomy surgery. This article documents some of these findings, specifically in relation to glaucoma surgery in the US.
A Historical Perspective on the EX-PRESS ® Glaucoma Filtration Device

A report on the presentation 'What is the EX-PRESS ® GFD and how is it different than a traditional trabeculectomy?' by Robert Fechtner
Dr Fechtner's presentation provided a broad overview of the EX-PRESS ® GFD and began by describing the EX-PRESS ® GFD and its
properties. The EX-PRESS ® GFD is a <3 mm long implant made from 316L medical grade stainless steel that is fully biocompatible with the eye (see Figure 1) . 28 , 30 The device comes with a spur to prevent extrusion and an end plate to prevent intrusion into the anterior chamber. It is non-valved and designed to divert aqueous away from the anterior chamber to the subconjunctival space, in a similar manner to a traditional trabeculectomy, with the flow being controlled by the diameter of the lumen. 28 In addition, a vertical slot in the end plate is designed to facilitate the generation of a diffuse bleb. 28 The P series EX-PRESS ® GFD is available with a lumen size of 50 or 200 μm.
Standardization of the lumen therefore makes one step of the trabeculectomy procedure more predictable.
Initial versions of the EX-PRESS ® GFD were implanted directly under the conjunctiva, but this led to excessive post-operative complications, including sustained hypotony, due to the lack of resistance to aqueous flow, subconjunctival scar tissue formation, endophthalmitis, and conjunctival erosions. [31] [32] [33] In 2005, the procedure was improved by implanting the EX-PRESS ® GFD under a half-thickness scleral flap. 34 In the initial description of the new procedure, IOP was well controlled at 24 months with few complications, transient hypotony being the most common. 34 Like a traditional trabeculectomy, the current EX-PRESS ® GFD implantation technique is therefore a guarded procedure. In 2007, the first study comparing guarded EX-PRESS ® GFD implantation with traditional trabeculectomy was published. 35 Following EX-PRESS ® GFD implantation in 50 eyes of 49 patients and trabeculectomy in 50 eyes of 47 patients, IOP reduction from baseline 34 was similar in both groups after 12 months (39.9 % and 42.1 %, respectively) with fewer incidences of early post-operative hypotony and choroidal effusion in those implanted with the EX-PRESS ® GFD. 35 This initial study therefore demonstrated EX-PRESS ® GFD implantation was as effective as traditional trabeculectomy in controlling IOP, with fewer post-operative complications.
Dr Fechtner then described the standard procedure for implantation of the EX-PRESS ® GFD (see Figure 2) . 34 The device has a financial cost. Dr Fechtner finished his presentation by saying that this cost may be offset, however, by potentially reduced lifetime costs to the healthcare system.
Long-term Evaluation of the EX-PRESS ® Glaucoma Filtration Device
A report on the presentation 'Improving the efficacy and predictability of filtration surgery with the EX-PRESS ® GFD-new 5 year study results comparing EX-PRESS ® GFD versus trabeculectomy' by Leo de Jong
As glaucoma is a lifelong disease, long-term studies evaluating IOP control with the EX-PRESS ® GFD versus traditional trabeculectomy are needed. In his presentation, Dr de Jong presented the recent findings Table 1 ). Moreover, the time to treatment failure for response criteria of complete success (see Figure 4 ) and partial success (with additional medication but no surgery) was significantly 
Compatibility of the EX-PRESS ® Glaucoma Filtration Device with Magnetic Resonance Imaging
A report on part of the presentation 'Improving patient visual recovery in filtration surgery: results from a newly published study on the EX-PRESS ® GFD' by Malik Kahook
Given its location following implantation, the safety of the EX-PRESS ® GFD for patients undergoing magnetic resonance imaging (MRI) is of paramount importance. MRI of the head is permitted, however not recommended, in the first two weeks post implantation. Although the EX-PRESS ® GFD is made of the highest medical grade stainless steel that is considered to be non-ferromagnetic, its compatibility with the different strength magnetic fields commonly used in MRI has yet to be fully determined.
The presentation by Dr Kahook contained his recent findings that used the American Society for Testing and Materials (ASTM) guidelines for MRI compatibility to examine the movement, force, and temperature change of individual EX-PRESS ® GFDs in different strength magnetic fields. 38 In magnetic fields of 1.5 and 3.0 T, individual EX-PRESS ® GFDs exhibited no rotation, no displacement, and minimal angular deflection (see Table 2 ). In addition, there was no apparent translational force or heating.
At 4.7 T there was considerable displacement of the device, which prevented accurate measurement of the amount of rotation, more angular deflection, and a greater amount of translational force compared with magnetic fields of 1.5 and 3.0 T. However, even at 4.7 T there was no heating of the device (see Table 2 ). According to the ASTM guidelines, the EX-PRESS ® GFD can therefore be considered MRI-compatible. 
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Real-life Experience Using the EX-PRESS ® Glaucoma Filtration Device
Conclusions
The EX-PRESS ® GFD is a valuable addition to the armamentarium of the glaucoma surgeon, allowing one variable of the trabeculectomy failure compared with traditional trabeculectomy. 37 In line with previous findings, 39 and as defined by stringent ASTM criteria, the EX-PRESS ® GFD is MRI-compatible 38 and does not compromise neurological scans, although it may affect MRI of the optic nerve. 40 Implantation of the EX-PRESS ® GFD can be successfully combined with other procedures, for instance cataract phacoemulsification, 41 or in cases where previous trabeculectomy surgical intervention has failed. 42 The EX-PRESS ® GFD is a viable alternative to primary trabeculectomy, can be used by any glaucoma surgeon skilled in trabeculectomy, and provides additional management options for the treatment of glaucoma. n
